See things differently - BIOVANCE® 3L Ocular tri-layer DDHAM
Celularity Inc (NASDAQ:CELU) is a clinical stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically-modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious & degenerative diseases.
Introducing BIOVANCE® 3L Ocular, a tri-layered, decellularized, dehydrated human amniotic membrane allograft derived from the placenta.
Brands: Biovance® 3L Ocular is a tri-layered, decellularized, dehydrated human amniotic membrane (DDHAM)